The Health Economics and Outcomes Research (hEOR) is a project of the Galen Centre for Health and Social Policy and seeks to support and inform healthcare decisions, views and statements with relevant scientific evidence.


Health Economics and Outcomes Research (hEOR), seeks to make significant positive contributions in healthcare by using relevant scientific evidence to inform healthcare decision-making in all strategies, policies and operations for all agencies.

hEOR supports better health care policies by offering insights in economics; and statistical analyses of critical issues. With that hEOR endeavours to use evidence based scientific analysis to help decision makers make informed, and timely decisions.


hEOR’s strategic perspective stresses on projects tackling policy and strategic issues that have effects on the present and will shape the future.

hEOR believes in working diligently, and closely with stakeholders, clients and external experts to: develop significant new policy insights; define strategies, and identify optimal choices.


L22, Common Ground
G016, Jaya One
72A, Jln Professor Diraja Ungku Aziz, Seksyen 13
46200 Petaling Jaya, Selangor, Malaysia

T: +6012 336 2338
E: [email protected]


  • Use relevant scientific evidence to “inform” better health care decision making
  • Drive health economics and outcomes research to connect into a complicated synergy between health systems; and economic theory, its models and techniques; and healthcare decisions made based on evidence
  • Build an active knowledge sharing community and network for health economics and outcomes research


Provides consultancy services for non-profit and for-profit purposes:

  • Scientific research based on evidence. This is based on the core of health economics, economic evaluations, budget impact analysis, value assessments and generations of real-world evidence.
  • Health economics training sessions: Typically all training sessions can be designed for all organizations. Academic excellence in all courses are monitored by a global panel of professors. Training is broken into basic, intermediate and advanced modules.
  • Knowledge sharing opportunities in the form of Health Economic Forums.
  • Personalized case studies and clinical studies upon contract and agreement.

informing healthcare decisions

The hEOR Team


Dr. June W. Y. Choon

Principal Science Officer

With more than 10 years of experience in pharmacy, Dr. June Choon began her career as a front-line hospital pharmacist but discovered very early on that her forte lay in academic pharmacy and related scientific research. She has done more than twenty bioavailability and bioequivalence studies for local pharmaceuticals during her Ph.D training in Universiti of Sains Malaysia.

Dr. Choon is a published former academic with Monash University, and in her eight years in tenure, she was appointed as Chair of the Monash Health Economics Forum and drove its knowledge sharing endeavours with support from the Pharmaceutical Services Division, Ministry of Health, Pharmaceutical Association of Malaysia (PhAMA). Simultaneously, Dr. Choon continued to train with the University of York. Where her focus research areas included: cardiovascular, psychiatry, oncology and real-world evidence. Also, throughout her career, she has sat in various research ethics committees and advisory for pharmaceuticals.